Seed giant Monsanto Co. earned a big win in the Supreme Court as SCOTUS unanimously upheld the previously issued $84,456 award to the company won in a high-profile case concerning a patent on Monsanto soybeans. The US Court of Appeals for the Federal Circuit upheld the award in 2011, in which a farmer from Indiana, found to have been re-growing herbicide-resistant soybeans instead of buying new seed from Monsanto. The most recent ruling from the Supreme Court, which upholds the award, has broader implications for patents on self-generating technologies, such as live vaccines, medical bacteria strains or genetically modified salmon. The Court noted, however, that their ruling was narrow and does not blanket all patents of the sort, recognizing the complexities of such technologies.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan